In the last year, the European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Pharmaceutical Privacy Consortium, and their partners in the research community have had fruitful discussions with legislators about EU data protection legislation and its potential impact on medical research in Europe. We would like to offer our view on the European Parliament report on the European Commission proposal for a General Data Protection Regulation adopted in plenary on 12 March.